|
Information for Vermont Prescribers of
Prescription Drugs
The
links below contain information provided pursuant to Vermont Law 33 V.S.A.
section 2005a which requires AWP discloure by
Pharmaceutical Marketers.
Adempas
Adempas Long_Form - January 2025
Adempas Short_Form - January 2025
Angeliq
Angeliq Long_Form - January 2025
Angeliq Short_Form - January 2025
Beyaz
Beyaz Long_Form - January 2025
Beyaz Short_Form - January 2025
Biltricide
Biltricide Long_Form - January 2025
Biltricide Short_Form - January 2025
Cipro
Cipro Long_Form - January 2025
Cipro Short_Form - January 2025
Kerendia
Kerendia Long_Form - January 2025
Kerendia Short_Form - January 2025
Lampit
Lampit Long_Form - January 2025
Lampit Short_Form - January 2025
Natazia
Natazia Long_Form - January 2025
Natazia Short_Form - January 2025
Nexavar
Nexavar Long_Form - January 2025
Nexavar Short_Form - January 2025
Nubeqa
Nubega Long_Form - January 2025
Nubega Short_Form - January 2025
Safyral
Safyral Long_Form - January 2025
Safyral Short_Form - January 2025
Stivarga
Stivarga Long_Form - January 2025
Stivarga Short_Form - January 2025
Vitrakvi
Vitrakvi Long_Form - January 2025
Vitrakvi Short_Form - January 2025
Yasmin
Yasmin Long_Form - January 2025
Yasmin Short_Form - January 2025
YAZ
Yaz Long_Form - January 2025
Yaz Short_Form - January 2025
|